Our findings suggest that the increase in PRMT1 expression in liver in obesity serves as a compensatory mechanism for the decrease in SAM to alleviate HFD-induced hepatic steatosis and liver damage by promoting fatty acid oxidation. The gene discussed is PRMT1; the disease is Hepatic steatosis.